Unknown

Dataset Information

0

EphrinB2 drives perivascular invasion and proliferation of glioblastoma stem-like cells.


ABSTRACT: Glioblastomas (GBM) are aggressive and therapy-resistant brain tumours, which contain a subpopulation of tumour-propagating glioblastoma stem-like cells (GSC) thought to drive progression and recurrence. Diffuse invasion of the brain parenchyma, including along preexisting blood vessels, is a leading cause of therapeutic resistance, but the mechanisms remain unclear. Here, we show that ephrin-B2 mediates GSC perivascular invasion. Intravital imaging, coupled with mechanistic studies in murine GBM models and patient-derived GSC, revealed that endothelial ephrin-B2 compartmentalises non-tumourigenic cells. In contrast, upregulation of the same ephrin-B2 ligand in GSC enabled perivascular migration through homotypic forward signalling. Surprisingly, ephrin-B2 reverse signalling also promoted tumourigenesis cell-autonomously, by mediating anchorage-independent cytokinesis via RhoA. In human GSC-derived orthotopic xenografts, EFNB2 knock-down blocked tumour initiation and treatment of established tumours with ephrin-B2-blocking antibodies suppressed progression. Thus, our results indicate that targeting ephrin-B2 may be an effective strategy for the simultaneous inhibition of invasion and proliferation in GBM.

SUBMITTER: Krusche B 

PROVIDER: S-EPMC4924994 | BioStudies | 2016-01-01

REPOSITORIES: biostudies

Similar Datasets

2010-01-01 | S-EPMC2801764 | BioStudies
2015-10-24 | E-GEOD-74304 | BioStudies
2019-01-01 | S-EPMC6851226 | BioStudies
2018-01-01 | S-EPMC6175027 | BioStudies
2015-01-01 | S-EPMC4119862 | BioStudies
2021-01-01 | S-EPMC7846610 | BioStudies
2015-10-24 | E-GEOD-74304 | ArrayExpress
2019-01-01 | S-EPMC6468443 | BioStudies
2020-01-01 | S-EPMC7037936 | BioStudies
2019-01-01 | S-EPMC6588602 | BioStudies